Century Therapeutics, Inc.
IPSCNasdaqCIK 1850119HealthcareFiscal year ends Dec 31
Reports and events: 109 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0212:18 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-113055 |
| 2026-09-0920:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-106312 |
| 2026-08-1212:12 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-094533 |
| 2026-08-1212:01 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-094523 |
| 2026-06-1620:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-26-074577 |
| 2026-06-1220:06 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-073429 |
| 2026-06-0820:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-071383 |
| 2026-05-1312:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-059824 |
| 2026-05-1312:01 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-059816 |
| 2026-04-2720:49 ET | DEF 14A | Proxy statementPeriod 2026-06-11 | 0001104659-26-049489 |
| 2026-03-2620:42 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-035256 |
| 2026-03-1212:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-026761 |
| 2026-03-1212:04 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-026759 |
| 2026-01-2321:05 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0001104659-26-006236 |
| 2026-01-1214:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-002748 |
| 2026-01-0813:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-001952 |
| 2025-12-2921:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-25-124836 |
| 2025-12-1221:08 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-120654 |
| 2025-12-0913:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-119494 |
| 2025-12-0221:05 ET | DEF 14A | Proxy statementPeriod 2026-01-22 | 0001104659-25-117704 |
| 2025-11-1312:52 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-110862 |
| 2025-11-1312:35 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-110851 |
| 2025-08-2920:10 ET | 8-K | 3.01 Delisting notice | 0001104659-25-085658 |
| 2025-08-1420:21 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-011575 |
| 2025-08-1420:17 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-078617 |
| 2025-07-0720:12 ET | 8-K | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors | 0001104659-25-066091 |
| 2025-06-1621:10 ET | 8-K | 5.07 Shareholder vote results | 0001104659-25-059950 |
| 2025-05-1520:15 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-007885 |
| 2025-05-1520:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-049454 |
| 2025-04-2220:06 ET | DEF 14A | Proxy statementPeriod 2025-06-12 | 0001104659-25-037419 |
| 2025-03-1920:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-025559 |
| 2025-03-1920:07 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-003299 |
| 2025-02-2821:10 ET | 8-K | 3.01 Delisting notice | 0001104659-25-019145 |
| 2025-01-1312:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-002841 |
| 2024-12-1322:00 ET | 8-K | 1.02 Termination of a material agreement | 0001104659-24-128491 |
| 2024-11-0514:10 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-114136 |
| 2024-11-0514:05 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-014345 |
| 2024-09-2611:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-24-102988 |
| 2024-08-0811:37 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-087013 |
| 2024-08-0811:30 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001558370-24-011467 |
| 2024-07-0820:33 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-078322 |
| 2024-06-2620:47 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001104659-24-075201 |
| 2024-06-2420:26 ET | 8-K | 5.07 Shareholder vote results | 0001104659-24-074339 |
| 2024-06-0311:13 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-067446 |
| 2024-05-0911:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-059124 |
| 2024-05-0911:30 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001558370-24-007469 |
| 2024-04-2620:08 ET | DEF 14A | Proxy statementPeriod 2024-06-20 | 0001104659-24-052924 |
| 2024-04-1121:25 ET | 8-K | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-046373 |
| 2024-04-1118:42 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-046247 |
| 2024-04-0910:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-044909 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.